Diabetes Drug Demonstrates Anti-Aging Benefits in Type 2 Patients
Originally Published 4 months ago — by Medical Xpress

A study shows that henagliflozin, a diabetes medication, significantly increases telomere length in patients with type 2 diabetes, suggesting potential anti-aging effects, though further research is needed to confirm these findings.
